Alexander Cumbo, EVP, Chief Commercial Officer at Sarepta Therapeutics, Inc. (SRPT), sold 42,000 shares at $125.50 ($5.3M) on 2019-12-13, disclosed to the SEC on 2019-12-17.
Open-market sale of $5.3M SRPT by EVP, Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $125.50 | 9,294 | $1.2M | 22.1% |
| 2 | $125.50 | 32,706 | $4.1M | 77.9% |
| Total | $125.50 avg | 42,000 | $5.3M | 100% |
| Filing → |
| SLDB | SELL | 2026-02-02 | $517K | — | Filing → |
| SLDB | SELL | 2025-12-04 | $110K | — | Filing → |
| SLDB | SELL | 2025-02-18 | $45K | — | Filing → |